Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - granisetron hydrochloride -

Ireland - English - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - granisetron hydrochloride - concentrate for solution for injection - 3mg/3ml - serotonin (5ht3) antagonists; granisetron

United States - English - NLM (National Library of Medicine)

wockhardt usa llc. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron hydrochloride injection is a serotonin-3 (5-ht3 ) receptor antagonist indicated for: - the prevention of nausea and/or vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. granisetron hydrochloride injection is contraindicated in patients with known hypersensitivity (eg. anaphylaxis, shortness of breath, hypotension, urticaria) to the drug or to any of its components. pregnancy  category  b reproduction studies have been performed in pregnant rats at intravenous doses up to 9 mg/kg/day (54 mg/m2 /day, 146 times the recommended human dose based on body surface area) and pregnant rabbits at intravenous doses up to 3 mg/kg/day (35.4 mg/m2 /day, 96 times the recommended human dose based on body surface area) and have revealed no evidence of impaired fertility or harm to the fetus due to granisetron. there are, however, no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predi

Canada - English - Health Canada

sandoz canada incorporated - granisetron (granisetron hydrochloride) - liquid - 1mg - granisetron (granisetron hydrochloride) 1mg - 5-ht3 receptor antagonists

Canada - English - Health Canada

sandoz canada incorporated - granisetron (granisetron hydrochloride) - solution - 1mg - granisetron (granisetron hydrochloride) 1mg - 5-ht3 receptor antagonists

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - granisetron hydrochloride, quantity: 1.12 mg/ml (equivalent: granisetron, qty 1 mg/ml) - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; citric acid monohydrate; sodium chloride - prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy in adults and children. prevention of nausea and vomiting induced by radiotherapy in adults only. prevention and treatment of post-operative nausea and vomiting in adults only.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - granisetron hydrochloride, quantity: 1.12 mg/ml (equivalent: granisetron, qty 1 mg/ml) - injection, concentrated - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; citric acid monohydrate; water for injections - prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy in adults and children. prevention of nausea and vomiting induced by radiotherapy in adults only. prevention and treatment of post-operative nausea and vomiting in adults only.

United States - English - NLM (National Library of Medicine)

avera mckennan hospital - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - granisetron hydrochloride - oral tablet - 1mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - granisetron hydrochloride - oral tablet - 1mg